InvestorsHub Logo
Post# of 252819
Next 10
Followers 36
Posts 3185
Boards Moderated 0
Alias Born 10/18/2003

Re: None

Monday, 07/23/2007 9:12:15 AM

Monday, July 23, 2007 9:12:15 AM

Post# of 252819
doesn't the ncst move look a little overdone

NUCRYST Pharmaceuticals receives FDA clearance of antimicrobial barrier topical cream
Thursday July 19, 4:30 pm ET


WAKEFIELD, MA, July 19 /PRNewswire-FirstCall/ - NUCRYST Pharmaceuticals Corp. today announced that the US Food & Drug Administration (FDA) has granted 510(k) clearance for a prescription topical cream containing NPI 32101, the company's patent-protected nanocrystalline silver, as a broad-spectrum antimicrobial barrier.
"NPI 32101 cream represents a new presentation of our patented nanocrystalline silver technology," said Scott H. Gillis, President & CEO, NUCRYST Pharmaceuticals Corp. "Gaining FDA clearance is a first step toward marketing our proprietary technology in this new formulation. We are actively exploring commercialization options and as part of this process, market plans and timing for this product will be determined."

In vitro studies have demonstrated that NPI 32101 cream serves as a broad-spectrum antimicrobial barrier to organisms including Pseudomonas aeruginosa and Staphylococcus aureus, including strains resistant to Methicillin (MRSA). Clinical studies involving more than 600 adults and children have also demonstrated that it has a strong safety profile.

NUCRYST Pharmaceuticals (NASDAQ: NCST - News; TSX: NCS - News) develops, manufactures and commercializes medical products that fight infection and inflammation using its patented atomically disordered nanocrystalline silver technology. Smith & Nephew plc sell a range of advanced wound care products under their Acticoat(TM) trade mark. Acticoat(TM) products incorporate NUCRYST's SILCRYST(TM) coatings and are sold in over 30 countries. NUCRYST is also developing pharmaceutical products to address medical conditions that are characterized by both infection and inflammation. The Company has developed its proprietary nanocrystalline silver in a powder form for use as an active pharmaceutical ingredient, referred to as NPI 32101.

SILCRYST(TM) is a trademark of NUCRYST Pharmaceuticals Corp. Acticoat(TM)

is a trademark of Smith & Nephew plc

Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.